These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 3908257)

  • 1. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
    König FK; Grewe R; Wörz K
    Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass].
    Fritz KW; Eglins P; Höge B; Hehrlein FW; Lüllwitz E; Kirchner E
    Intensivmed Prax; 1982 Jun; 5():27-38. PubMed ID: 6984020
    [No Abstract]   [Full Text] [Related]  

  • 4. [Duration of the antianginal effect of oral molsidomine in exertion angina. Double-blind, crossed and randomized study].
    Bordes P; Gimeno JV; Olagüe J; Ferrer J; Hernández M; Algarra F
    Rev Esp Cardiol; 1986; 39(2):138-42. PubMed ID: 3523649
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine.
    Jansen W; Tauchert M; Osterspey A; Hombach V; Fuchs M; Hilger HH
    Z Kardiol; 1983; 72 Suppl 3():203-10. PubMed ID: 6689389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of molsidomin in ischemic cardiopathy].
    Di Giacomo G; Nicolella U; Puligheddu M; Tripodi A; D'Ascoli C; Di Virgilio D
    Clin Ter; 1984 Oct; 111(2):141-6. PubMed ID: 6239736
    [No Abstract]   [Full Text] [Related]  

  • 9. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
    Rudolph W
    Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of the preparation korvatone].
    Charchoglian RA; Esin NN; Belozerov GE
    Sov Med; 1982; (5):15-8. PubMed ID: 7051350
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative examinations of the effectiveness of Molsidomin and nitrates in angina pectoris].
    Lehmann HU; Ziegler G; Hochrein H
    Med Welt; 1980 Jul; 31(29-30):1099-103. PubMed ID: 6774198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.
    Martorana PA; Kettenbach B; Göbel H; Nitz RE
    Basic Res Cardiol; 1984; 79(5):503-12. PubMed ID: 6439183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

  • 17. [Molsidomin compared to nitrates. Use in patients with manifest coronary disease].
    Lehmann HU; Brix W; Hochrein H
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1149-51. PubMed ID: 40120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term clinical and hemodynamic results of the treatment of refractory cardiac failure with molsidomine].
    Kulas A; Escudier B; Hannachi N; Kolski H; Witchitz S; Acar J
    Arch Mal Coeur Vaiss; 1984 Jan; 77(1):92-9. PubMed ID: 6422898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of korvatone on the hemodynamic indices of rheumatism patients].
    Sokolov AM; Suloeva MN
    Vrach Delo; 1984 Jul; (7):83-6. PubMed ID: 6548064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Relation between therapeutic efficacy of antianginal preparations in patients with ischemic heart disease and their effect on the rheologic properties of blood].
    Furkalo NK; Ivashchenko TI; Romanenko AI
    Kardiologiia; 1985 Sep; 25(9):55-9. PubMed ID: 3935849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.